April 30, 2020 / 4:16 PM / a month ago

BRIEF-Kiadis Pharma FY Operating Loss Widens To 73.2 Million Euros

April 30 (Reuters) - Kiadis Pharma NV:

* FY OPERATING LOSS -73.2 MILLION EUR VERSUS -25.2 MILLION EUR LOSS YEAR AGO

* UNDILUTED LOSS PER SHARE FOR 2019 INCREASED TO EUR 1.92 COMPARED TO EUR 1.46 IN 2018

* AS A RESULT OF OVERALL INCREASE IN TOTAL OPERATING EXPENSES, GROUP’S OPERATING LOSS INCREASED FROM EUR 25.2 MILLION IN 2018 TO EUR 73.2 MILLION IN 2019

* NET LOSS FOR YEAR INCREASED BY EUR 22.8 MILLION TO EUR 52.6 MILLION IN 2019 VERSUS LOSS OF EUR 29.8 MILLION IN 2018

* TOTAL CASH AND CASH EQUIVALENTS DECREASED BY EUR 30.8 MILLION FROM EUR 60.3 MILLION AT YEAR-END 2018 TO EUR 29.5 MILLION AT END OF 2019 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below